Jeff Hensel

Jeff Hensel has a diverse work experience in the pharmaceutical and consulting industries. Jeff started their career as a Healthcare Investment Banking Analyst at Banc of America Securities and later worked as a Financial & Business Development Analyst at Barr Laboratories. Jeff then joined L.E.K. Consulting as a Consultant before moving to Booz & Company as an Engagement Manager, where they specialized in strategy, operations, and marketing consulting for biopharma and health insurance clients. Hensel then joined Biogen, where they held various roles including Associate Director, Strategic Forecasting Lead for Multiple Sclerosis, Director, Global Strategic Forecasting, and Disease Area Lead, Early & External Product Commercialization. Currently, they are working at Agios Pharmaceuticals as the Senior Director of Corporate Development and Strategy, and starting from 2023, they will transition to the role of Vice President, Corporate Development.

Jeff Hensel completed their MBA degree in Healthcare Management from The Wharton School between 2005 and 2007. Prior to that, they pursued a Bachelor of Arts degree in Economics and Operations Research from Columbia University from 1997 to 2001. Jeff'searliest education is from Spanish River High School, although specific years or degrees obtained are not provided.